Arturo Molina M.D., Chief Medical Officer at Protagonist Therapeutics, Inc (PTGX), sold 23,151 shares at $82.42 ($1.9M) on 2026-01-23, disclosed to the SEC on 2026-01-27.
Seasonal sale ($1.9M) by Chief Medical Officer — this insider has traded PTGX in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.42 | 13,151 | $1.1M | 56.9% |
| 2 | $82.28 | 5,000 | $411K | 21.6% |
| 3 | $82.00 | 5,000 | $410K | 21.5% |
| Total | $82.30 avg | 23,151 | $1.9M | 100% |
| Filing → |
| PTGX | SELL | 2025-11-19 | $460K | — | Filing → |
| PTGX | SELL | 2025-06-11 | $1.1M | — | Filing → |
| PTGX | SELL | 2025-03-14 | $3.4M | — | Filing → |